Skip to main content
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
zeinmersini.besharat@uniroma1.it
Zein Mersini Besharat
Ricercatore
Struttura:
DIPARTIMENTO DI MEDICINA SPERIMENTALE
E-mail:
zeinmersini.besharat@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Publications
Title
Published on
Year
MiR-326: Role and significance in brain cancers
NON-CODING RNA RESEARCH
2025
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients
CURRENT ONCOLOGY REPORTS
2024
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers?
PHARMACOLOGY & THERAPEUTICS
2024
Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling
NPJ PRECISION ONCOLOGY
2024
Notch3-regulated microRNAs impair CXCR4- CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL
ONCOGENE
2024
Notch3-regulated microRNAs impair CXCR4-dependent maturation of thymocytes allowing maintenance and progression of T-ALL
ONCOGENE
2024
Bisphenol-A in Drinking Water Accelerates Mammary Cancerogenesis and Favors an Immunosuppressive Tumor Microenvironment in BALB–neuT Mice
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
2024
Building an in vitro model of sarcopenic obesity
INTERNATIONAL JOURNAL OF BONE FRAGILITY
2024
New Advances in Metabolic Syndrome, from Prevention to Treatment: The Role of Diet and Food
NUTRIENTS
2023
Hedgehog-GLI and Notch Pathways Sustain Chemoresistance and Invasiveness in Colorectal Cancer and Their Inhibition Restores Chemotherapy Efficacy
CANCERS
2023
Prospective validation study of a novel integrated pathway based on clinical features, MRI biomarkers and microRNAs for early detection of prostate cancer
EUROPEAN UROLOGY ONCOLOGY
2023
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2023
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance
BIOMÉDECINE & PHARMACOTHÉRAPIE
2023
Tumor Microenvironment Remodeling in Gastrointestinal Cancer: Role of miRNAs as Biomarkers of Tumor Invasion
BIOMEDICINES
2023
KCTD1 is a new modulator of the KCASH family of Hedgehog suppressors
NEOPLASIA
2023
Network analysis identifies circulating miR-155 as predictive biomarker of type 2 diabetes mellitus development in obese patients: a pilot study
SCIENTIFIC REPORTS
2023
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value
BIOMARKER RESEARCH
2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancer
ENDOCRINE
2023
Environmental contaminants acting as endocrine disruptors modulate atherogenic processes: New risk factors for cardiovascular diseases in women?
BIOMOLECULES
2022
MicroRNA loaded edible nanoparticles: an emerging personalized therapeutic approach for the treatment of obesity and metabolic disorders
THERANOSTICS
2022
1
2
3
next >
last »
ERC
LS2_10
LS3_8
LS3_12
LS4_5
LS4_6
KET
Big data & computing
Life-science technologies & biotechnologies
Interessi di ricerca
Progetti di Ricerca
Evaluation of circulating microRNAs in medulloblastoma as prognostic biomarkers
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma